Autolus Therapeutics dismissed Ernst & Young LLP (UK) and appointed Ernst & Young LLP (US) as its new independent registered public accounting firm, effective April 14, 2026.
Key takeaways
Audit Committee dismissed Ernst & Young LLP (UK) on April 14, 2026, with no disagreements reported during the two most recent fiscal years.
Ernst & Young LLP (US) was appointed as the new independent auditor for the fiscal year ending December 31, 2026, effective immediately.
Previous audit reports for fiscal years 2024 and 2025 did not contain adverse opinions or disclaimers of opinion.
Material weaknesses in internal controls were initially disclosed in the Q1 2024 Form 10-Q, though not noted as a disagreement with the auditor.